Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases.
about
Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cellsMolecular regulation of bone marrow metastasis in prostate and breast cancerMacrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy.The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species.RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapySix degrees of separation: the oxygen effect in the development of radiosensitizers.Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRI.Nitric oxide and cancer: a review.Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.RKIP: much more than Raf kinase inhibitory protein.Effects of nitric oxide on the biological behavior of HepG2 human hepatocellular carcinoma cells.Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells.Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.H89 enhances the sensitivity of cancer cells to glyceryl trinitrate through a purinergic receptor-dependent pathway.A comparative study on immunomodulatory activity of polysaccharides from two official species of Ganoderma (Lingzhi).Synergistic interaction of β-galactosyl-pyrrolidinyl diazeniumdiolate with cisplatin against three tumor cells.Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers.Co-delivery of nitric oxide and antibiotic using polymeric nanoparticles.Nitric oxide and cancer.O2-(6-Oxocyclohex-1-en-1-yl)methyl diazen-1-ium-1,2-diolates: a new class of nitric oxide donors activatable by GSH/GSTπ with both anti-proliferative and anti-metastatic activities against melanoma.RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and ImpactArginine and the metabolic regulation of nitric oxide synthesis in cancer
P2860
Q28468523-205B6A8A-FB91-4BFC-88AB-0D9751487945Q34053030-9EEA6340-B2F1-40D1-9523-8B986A8799C9Q34243432-CF54C02C-61AD-4573-926A-0C685DEB7A85Q34552077-2D81AEEE-61FD-4E8D-992E-032490B9D03DQ34634649-A7FAFEEC-6308-4D4F-9782-2A58EB046BD3Q35116798-C51FDD14-F84D-4179-A0D3-34512B84A259Q36741601-41D6125C-2DE8-44F4-A494-9443FE6080D5Q36893209-11ADB32B-73F8-42B2-AA30-CA5F7B3D422FQ36998275-6B96BC6B-E534-48F9-95FA-780D0EAF7B0AQ38077517-BB3504CF-65C0-42FE-AE5A-12C9A301441AQ38771692-42D0BB23-8525-4CF5-B167-A440F70D98B3Q38821993-87007990-2D91-4994-836B-B965B9A31213Q38850012-43424CF3-FCDC-436F-BB52-1D893F180AA5Q38900900-DDBAAAAF-4C7C-4EF5-A946-1AA7CFB6BEE6Q38958110-87DEEDD0-014B-49DB-B550-0FB61D7957C2Q39180937-E5D67396-F804-4278-9F83-2F57896A9C2AQ39243266-4AA614B5-F4F1-4058-9405-983AF6F8824EQ40811988-6EE8051E-CD6D-4A95-B401-E387F24ADFACQ41127967-8ADC5A55-CB1C-4E19-98D2-4E75BAFD39FFQ53342374-D25B3A6E-D6B5-49DF-880B-D540AA5F5FF7Q58704356-4B65D07E-E5E9-460C-ACF6-4FAAC473BFACQ58798459-7A0E5395-62BE-45BE-9246-B19D3425A34F
P2860
Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel therapeutic applications ...... and inhibition of metastases.
@en
Novel therapeutic applications ...... and inhibition of metastases.
@nl
type
label
Novel therapeutic applications ...... and inhibition of metastases.
@en
Novel therapeutic applications ...... and inhibition of metastases.
@nl
prefLabel
Novel therapeutic applications ...... and inhibition of metastases.
@en
Novel therapeutic applications ...... and inhibition of metastases.
@nl
P2093
P1433
P1476
Novel therapeutic applications ...... s and inhibition of metastases
@en
P2093
Benjamin Bonavida
Devasis Chatterjee
Sara Huerta-Yepez
Stavroula Baritaki
P304
P356
10.1016/J.NIOX.2008.04.018
P577
2008-04-24T00:00:00Z